Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjustment of Aminoglycoside Dosing Based on Peak Serum Concentration and Bacterial Minimal Inhibitory Concentration

NCT05618457 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT05618457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05618457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjustment of Aminoglycoside Dosing Based on Peak Serum Concentration and Bacterial Minimal Inhibitory Concentration
Lead sponsor
Hadassah Medical Organization
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2021
Completion date
December 31, 2025
Enrollment
151 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aminoglycoside dosing based on pk/pd characteristics